Financial Daily from THE HINDU group of publications
Thursday, Feb 03, 2005

Port Info

Group Sites

Industry & Economy - Health

Narcotics deadlock — Drug shortages hit epilepsy, anxiety post-operative care

P.T. Jyothi Datta

Mumbai , Feb. 2

PATIENTS consuming the anti-epileptic drug Gardenal for several years are now being faced with a shortage of the medicine in the market.

"Anti-epilepsy drugs have to be consumed everyday to prevent epileptic fits from coming on," says an official with the drug company Nicholas Piramal — who is already receiving letters from patients and doctors asking for supply of the medicine, following the shortage in the market.

Gardenal, Valium, Garoin (also for epilepsy), Rivotril (an anxiety drug) etc. are just few of the estimated Rs 1,000 crore basket of psychotropic and central nervous system (CNS) drugs that are hit by the fear-psychosis spreading among chemists and medicine retailers across the country.

In a self-imposed freeze effective from Tuesday, wholesalers and retailers have stopped purchasing this segment of drugs from companies - for fear of raids from the Narcotics Control Bureau (NCB).

And the shortage of drugs will get more acute across the country, as the existing socks of the medicine dry-up, says Mr J.S. Shinde, General Secretary of the All India Organisation of Chemists and Druggists (AIOCD).

According to him, chemists and medicine retailers are witnessing increased raids by the NCB to prevent the abuse of medicines that come under the Narcotic Drugs and Psychotropic Substances Act (NDPS), 1985. Chemists are expected to maintain records on the purchase of these drugs from the companies and it's subsequent sale to patients for a period of two-years. And the absence of this can throw them behind bars without bail, says Mr Shinde.

Repeated efforts by the AIOCD to meet the Union Health Minister have not fructified, he said and the organisation is now set to intensify its stir. The AIOCD wants this segment of drugs to be brought only under the Drugs and Cosmetics Act, away from the NDPS Act.

The abuse of these drugs as intoxicants can be fixed through other, less harassing methods, the AIOCD official feels.

Caught in this stalemate are companies such as Torrent, Cipla, Ranbaxy, Sun Pharma, Nicholas Piramal, Wockhardt, Intas, Zydus, Ajanta Pharma, Novartis... .the list goes on.

Ranbaxy for instance markets Pentazocine, a drug used as a post-operative in surgeries such as cancer. It also markets Diazepam, or anti-depressant better known as Calmpose.

While sales from these drugs are small, a Ranbaxy spokesperson said "sales have come to a virtual halt for these products," as a result of the AIOCD call.

Wockhardt too admitted to "some confusion" in the market, with retailers being reluctant to stock it's product dextropropoxyphene or the Proxyvon range of medicines.

And as the stalemate remains to be sorted out by the Government, consumers are already taking the brunt of the dead-lock.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
HDFC Chubb plans weather cover

Revocation of dumping duty on Vitamin A Palmitate recommended
BCCI an autonomous body, says SC
Economic advisory panel to look at ways to increase credit flow
Protest meet highlights need to protect mangroves
SAARC Limited Multilateral pact gets Cabinet nod
Narcotics deadlock — Drug shortages hit epilepsy, anxiety post-operative care
Dr Reddy's to take up trials of drug for side-effects of radiation therapy
Reliance hikes petrochem prices
`UK decision may lead to greater awareness on use of statins'
NTPC arm to enter distribution biz in Mangalore circle
Govt approves electricity policy — Aim to increase per capita availability to over 1,000 units
New ED for NTPC South
States to get 30 pc share in Central taxes
Uncertainty over Indo-Pak series telecast rights
TDSAT adjourns Zee-Turner, Asianet case till Feb 16
Five institutions brought under SRM deemed university
JNTU signs pact with Infotech for staff training programme
UK international school in AP
Food processing incubator at TNAU
FICCI urges Govt to promote investment in real estate sector
Advancing technology offers infinite possibilities
FDI cap in telecom hiked to 74 pc
Singapore group may hike stake in Idea Cellular
Left to discuss hike today
Tatas upbeat; Hutch may consolidate operations
Experts seek changes to Competition Act
Ideal Home expo from Feb 4 to 14 in Madurai
Seminar on product patents
Tanneries workshop
Valentine's season may be mixed for flower exports
Fish out of water
Contributions to The Hindu Relief Fund

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line